Ad4-mgag

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Emergent BioSolutions

Conditions

HIV VaccineHealthy VolunteerVaccine Response

Phase 1

Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers

CompletedNCT01989533

National Institute of Allergy and Infectious Diseases (NIAID)Vaccine Response

Start: 2013-11-19End: 2019-04-08Updated: 2019-12-17

Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected Adults

TerminatedNCT02771730

Emergent BioSolutionsHealthy Volunteer, HIV Vaccine

Start: 2015-03-31End: 2017-02-28Updated: 2024-03-18